|
1
|
Cao M and Chen W: Epidemiology of lung
cancer in China. Thorac Cancer. 10:3–7. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kalemkerian GP: Small Cell Lung Cancer.
Semin Respir Crit Care Med. 37:783–796. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pelton K, Coticchia CM, Curatolo AS,
Schaffner CP, Zurakowski D, Solomon KR and Moses MA:
Hypercholesterolemia induces angiogenesis and accelerates growth of
breast tumors in vivo. Am J Pathol. 184:2099–2110. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ott PA, Elez E, Hiret S, Kim DW, Morosky
A, Saraf S, Piperdi B and Mehnert JM: Pembrolizumab in patients
with extensive-stage small-cell lung cancer: Results from the phase
Ib KEYNOTE-028 Study. J Clin Oncol. 35:3823–3829. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fan Y and Mao W: Immune checkpoint
inhibitors in lung cancer: Current status and future directions.
Chin Clin Oncol. 6:172017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tanvetyanon T, Gray JE and Antonia SJ:
PD-1 checkpoint blockade alone or combined PD-1 and CTLA-4 blockade
as immunotherapy for lung cancer? Expert Opin Biol Ther.
17:305–312. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ready N, Farago AF, de Braud F, Atmaca A,
Hellmann MD, Schneider JG, Spigel DR, Moreno V, Chau I, Hann CL, et
al: Third-line nivolumab monotherapy in recurrent SCLC: CheckMate
032. J Thorac Oncol. 14:237–244. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Souza-Fonseca-Guimaraes F, Cursons J and
Huntington ND: The emergence of natural killer cells as a major
target in cancer immunotherapy. Trends Immunol. 40:142–158. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cai X, Caballero-Benitez A, Gewe MM,
Jenkins IC, Drescher CW, Strong RK, Spies T and Groh V: Control of
tumor initiation by NKG2D naturally expressed on ovarian cancer
cells. Neoplasia. 19:471–482. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bauer S, Groh V, Wu J, Steinle A, Phillips
JH, Lanier LL and Spies T: Activation of NK cells and T cells by
NKG2D, a receptor for stress-inducible MICA. Science. 285:727–729.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Diefenbach A, Jamieson AM, Liu SD, Shastri
N and Raulet DH: Ligands for the murine NKG2D receptor: Expression
by tumor cells and activation of NK cells and macrophages. Nat
Immunol. 1:119–126. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cosman D, Mullberg J, Sutherland CL, Chin
W, Armitage R, Fanslow W, Kubin M and Chalupny NJ: ULBPs, novel MHC
class I-related molecules, bind to CMV glycoprotein UL16 and
stimulate NK cytotoxicity through the NKG2D receptor. Immunity.
14:123–133. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Eagle RA, Traherne JA, Hair JR, Jafferji I
and Trowsdale J: ULBP6/RAET1L is an additional human NKG2D ligand.
Eur J Immunol. 39:3207–3216. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu H, Wang S, Xin J, Wang J, Yao C and
Zhang Z: Role of NKG2D and its ligands in cancer immunotherapy. Am
J Cancer Res. 9:2064–2078. 2019.PubMed/NCBI
|
|
15
|
Lopez-Soto A, Huergo-Zapico L,
Acebes-Huerta A, Villa-Alvarez M and Gonzalez S: NKG2D signaling in
cancer immunosurveillance. Int J Cancer. 136:1741–1750. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lanier LL: NKG2D Receptor and Its Ligands
in Host Defense. Cancer Immunol Res. 3:575–582. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Inagaki A, Ishida T, Yano H, Ishii T,
Kusumoto S, Ito A, Ri M, Mori F, Ding J, Komatsu H, et al:
Expression of the ULBP ligands for NKG2D by B-NHL cells plays an
important role in determining their susceptibility to
rituximab-induced ADCC. Int J Cancer. 125:212–221. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Travis WD, Brambilla E, Burke AP, Marx A
and Nicholson AG: Introduction to The 2015 World Health
Organization classification of tumors of the lung, pleura, thymus,
and heart. J Thorac Oncol. 10:1240–1242. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Eisenhauer EA, Therasse P, Bogaerts J,
Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S,
Mooney M, et al: New response evaluation criteria in solid tumours:
Revised RECIST guideline (version 1.1). Eur J Cancer. 45:228–247.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fan Y, Gan Y, Shen Y, Cai X, Song Y, Zhao
F, Yao M, Gu J and Tu H: Leptin signaling enhances cell invasion
and promotes the metastasis of human pancreatic cancer via
increasing MMP-13 production. Oncotarget. 6:16120–16134. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wu Y, Gan Y, Yuan H, Wang Q, Fan Y, Li G,
Zhang J, Yao M, Gu J and Tu H: Enriched environment housing
enhances the sensitivity of mouse pancreatic cancer to
chemotherapeutic agents. Biochem Biophys Res Commun. 473:593–599.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Barrett T, Troup DB, Wilhite SE, Ledoux P,
Rudnev D, Evangelista C, Kim IF, Soboleva A, Tomashevsky M,
Marshall KA, et al: NCBI GEO: Archive for high-throughput
functional genomic data. Nucleic Acids Res. 37:885–890. 2009.
View Article : Google Scholar
|
|
24
|
Breitkreutz BJ, Stark C, Reguly T, Boucher
L, Breitkreutz A, Livstone M, Oughtred R, Lackner DH, Bähler J,
Wood V, et al: The BioGRID Interaction Database: 2008 update.
Nucleic Acids Res. 36:D637–D640. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Brown KR and Jurisica I: Online predicted
human interaction database. Bioinformatics. 21:2076–2082. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Keshava Prasad TS, Goel R, Kandasamy K,
Keerthikumar S, Kumar S, Mathivanan S, Telikicherla D, Raju R,
Shafreen B, Venugopal A, et al: Human protein reference
database-2009 update. Nucleic Acids Res. 37:767–772. 2009.
View Article : Google Scholar
|
|
27
|
Romero P, Wagg J, Green ML, Kaiser D,
Krummenacker M and Karp PD: Computational prediction of human
metabolic pathways from the complete human genome. Genome Biol.
6:R22005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Aranda B, Achuthan P, Alam-Faruque Y,
Armean I, Bridge A, Derow C, Feuermann M, Ghanbarian AT, Kerrien S,
Khadake J, et al: The IntAct molecular interaction database in
2010. Nucleic Acids Res. 38:D525–D531. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ceol A, Chatr Arayamontri A, Licata L,
Peluso D, Briganti L, Perfetto L, Castagnoli L and Cesareni G:
MINT, the molecular interaction database: 2009 update. Nucleic
Acids Res. 38:D532–D539. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Schaefer CF, Anthony K, Krupa S, Buchoff
J, Day M, Hannay T and Buetow KH: PID: The pathway interaction
database. Nucleic Acids Res. 37:D674–D679. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Vastrik I, D'Eustachio P, Schmidt E,
Gopinath G, Croft D, de Bono B, Gillespie M, Jassal B, Lewis S,
Matthews L, et al: Reactome: A knowledge base of biologic pathways
and processes. Genome Biol. 8:R392007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Warde-Farley D, Donaldson SL, Comes O,
Zuberi K, Badrawi R, Chao P, Franz M, Grouios C, Kazi F, Lopes CT,
et al: The GeneMANIA prediction server: Biological network
integration for gene prioritization and predicting gene function.
Nucleic Acids Res. 38((Web Server issue)): W214–W220. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wu Y, Si R, Tang H, He Z, Zhu H, Wang L,
Fan Y, Xia S, He Z and Wang Q: Cholesterol reduces the sensitivity
to platinum-based chemotherapy via upregulating ABCG2 in lung
adenocarcinoma. Biochem Biophys Res Commun. 457:614–620. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Shukla S, Robey RW, Bates SE and Ambudkar
SV: The calcium channel blockers, 1,4-dihydropyridines, are
substrates of the multidrug resistance-linked ABC drug transporter,
ABCG2. Biochemistry. 45:8940–8951. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wu Y, Si R, Yang S, Xia S, He Z, Wang L,
He Z, Wang Q and Tang H: Depression induces poor prognosis
associates with the down-regulation brain derived neurotrophic
factor of serum in advanced small cell lung cancer. Oncotarget.
7:85975–85986. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hu J, Zhu S, Xia X, Zhang L, Kleinerman ES
and Li S: CD8+T cell-specific induction of NKG2D receptor by
doxorubicin plus interleukin-12 and its contribution to CD8+T cell
accumulation in tumors. Mol Cancer. 13:342014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Raffaghello L, Prigione I, Airoldi I,
Camoriano M, Levreri I, Gambini C, Pende D, Steinle A, Ferrone S
and Pistoia V: Downregulation and/or release of NKG2D ligands as
immune evasion strategy of human neuroblastoma. Neoplasia.
6:558–568. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Dhar P and Wu JD: NKG2D and its ligands in
cancer. Curr Opin Immunol. 51:55–61. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhang J, Basher F and Wu JD: NKG2D ligands
in tumor immunity: Two sides of a coin. Front Immunol. 6:972015.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Deng W, Gowen BG, Zhang L, Wang L, Lau S,
Iannello A, Xu J, Rovis TL, Xiong N and Raulet DH: Antitumor
immunity. A shed NKG2D ligand that promotes natural killer cell
activation and tumor rejection. Science. 348:136–139. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zen K, Karsan A, Stempien-Otero A, Yee E,
Tupper J, Li X, Eunson T, Kay MA, Wilson CB, Winn RK and Harlan JM:
NF-kappaB activation is required for human endothelial survival
during exposure to tumor necrosis factor-alpha but not to
interleukin-1beta or lipopolysaccharide. J Biol Chem.
274:28808–28815. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Theodoulou FL and Kerr ID: ABC transporter
research: Going strong 40 years on. Biochem Soc Trans.
43:1033–1040. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Boswell-Casteel RC, Fukuda Y and Schuetz
JD: ABCB6, an ABC transporter impacting drug response and disease.
AAPS J. 20:82017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Gillet JP and Gottesman MM: Advances in
the molecular detection of ABC transporters involved in multidrug
resistance in cancer. Curr Pharm Biotechnol. 12:686–692. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Huang Y, Penchala S, Pham AN and Wang J:
Genetic variations and gene expression of transporters in drug
disposition and response. Expert Opin Drug Metab Toxicol.
4:237–254. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zinzi L, Capparelli E, Cantore M, Contino
M, Leopoldo M and Colabufo NA: Small and innovative molecules as
new strategy to revert MDR. Front Oncol. 4:22014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Colabufo NA, Berardi F, Contino M, Niso M
and Perrone R: ABC pumps and their role in active drug transport.
Curr Top Med Chem. 9:119–129. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Xie N, Mou L, Yuan J, Liu W, Deng T, Li Z,
Jing Y and Hu Z: Modulating drug resistance by targeting BCRP/ABCG2
using retrovirus-mediated RNA interference. PLoS One.
9:e1034632014. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
de Boussac H, Orban TI, Varady G, Tihanyi
B, Bacquet C, Brózik A, Váradi A, Sarkadi B and Arányi T:
Stimulus-induced expression of the ABCG2 multidrug transporter in
HepG2 hepatocarcinoma model cells involves the ERK1/2 cascade and
alternative promoters. Biochem Biophys Res Commun. 426:172–176.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Benderra Z, Faussat AM, Sayada L, Perrot
JY, Chaoui D, Marie JP and Legrand O: Breast cancer resistance
protein and P-glycoprotein in 149 adult acute myeloid leukemias.
Clin Cancer Res. 10:7896–7902. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Yewdell JW: Not such a dismal science: The
economics of protein synthesis, folding, degradation and antigen
processing. Trends Cell Biol. 11:294–297. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Patel A, Li TW, Anreddy N, Wang DS, Sodani
K, Gadhia S, Kathawala R, Yang DH, Cheng C and Chen ZS: Suppression
of ABCG2 mediated MDR in vitro and in vivo by a novel inhibitor of
ABCG2 drug transport. Pharmacol Res. 121:184–193. 2017. View Article : Google Scholar : PubMed/NCBI
|
